---
document_datetime: 2024-07-12 09:18:19
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/invega-epar-all-authorised-presentations_en.pdf
document_name: invega-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 3.4355421
conversion_datetime: 2025-12-30 21:17:20.22578
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | (Invented) name   | Strength   | Pharmaceutical form      | Route of administration   | Immediate Packaging       | Pack size   |
|-----------------|-------------------|------------|--------------------------|---------------------------|---------------------------|-------------|
| EU/1/07/395/041 | Invega            | 3 mg       | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 28 tablets  |
| EU/1/07/395/042 | Invega            | 3 mg       | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 49 tablets  |
| EU/1/07/395/043 | Invega            | 3 mg       | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 56 tablets  |
| EU/1/07/395/044 | Invega            | 3 mg       | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 98 tablets  |
| EU/1/07/395/045 | Invega            | 6 mg       | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 28 tablets  |
| EU/1/07/395/046 | Invega            | 6 mg       | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 49 tablets  |
| EU/1/07/395/047 | Invega            | 6 mg       | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 56 tablets  |
| EU/1/07/395/048 | Invega            | 6 mg       | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 98 tablets  |
| EU/1/07/395/049 | Invega            | 9 mg       | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 28 tablets  |
| EU/1/07/395/050 | Invega            | 9 mg       | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 49 tablets  |
| EU/1/07/395/051 | Invega            | 9 mg       | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 56 tablets  |
| EU/1/07/395/052 | Invega            | 9 mg       | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 98 tablets  |
| EU/1/07/395/053 | Invega            | 12 mg      | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 28 tablets  |
| EU/1/07/395/054 | Invega            | 12 mg      | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 49 tablets  |
| EU/1/07/395/055 | Invega            | 12 mg      | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 56 tablets  |
| EU/1/07/395/056 | Invega            | 12 mg      | Prolonged release tablet | Oral use                  | blister (OPA-Alu-PVC/Alu) | 98 tablets  |
| EU/1/07/395/057 | Invega            | 3 mg       | Prolonged release tablet | Oral use                  | Bottle (HDPE/PP)          | 30 tablets  |
| EU/1/07/395/058 | Invega            | 3 mg       | Prolonged release tablet | Oral use                  | Bottle (HDPE/PP)          | 350 tablets |
| EU/1/07/395/059 | Invega            | 6 mg       | Prolonged release tablet | Oral use                  | Bottle (HDPE/PP)          | 30 tablets  |
| EU/1/07/395/060 | Invega            | 6 mg       | Prolonged release tablet | Oral use                  | Bottle (HDPE/PP)          | 350 tablets |
| EU/1/07/395/061 | Invega            | 9 mg       | Prolonged release tablet | Oral use                  | Bottle (HDPE/PP)          | 30 tablets  |
| EU/1/07/395/062 | Invega            | 9 mg       | Prolonged release tablet | Oral use                  | Bottle (HDPE/PP)          | 350 tablets |
| EU/1/07/395/063 | Invega            | 12 mg      | Prolonged release tablet | Oral use                  | Bottle (HDPE/PP)          | 30 tablets  |
| EU/1/07/395/064 | Invega            | 12 mg      | Prolonged release tablet | Oral use                  | Bottle (HDPE/PP)          | 350 tablets |
| EU/1/07/395/067 | Invega            | 3 mg       | Prolonged release tablet | Oral use                  | blister (OPA-alu-PVC/alu) | 14 tablets  |
| EU/1/07/395/070 | Invega            | 6 mg       | Prolonged release tablet | Oral use                  | blister (OPA-alu-PVC/alu) | 14 tablets  |
| EU/1/07/395/073 | Invega            | 9 mg       | Prolonged release tablet | Oral use                  | blister (OPA-alu-PVC/alu) | 14 tablets  |
| EU/1/07/395/076 | Invega            | 12 mg      | Prolonged release tablet | Oral use                  | blister (OPA-alu-PVC/alu) | 14 tablets  |